{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:57:05Z","timestamp":1792789025367,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/inf.0000000000001048","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T11:11:19Z","timestamp":1452251479000},"page":"407-413","source":"Crossref","is-referenced-by-count":28,"title":["The Burden of Pediatric Invasive Meningococcal Disease in Spain (2008\u20132013)"],"prefix":"10.1097","volume":"35","author":[{"given":"Irene","family":"Rivero-Calle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Vilanova-Trillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo","family":"Pardo-Seco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia Blanco","family":"Salvado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Illade","family":"Quinteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Martinon-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-12-20210202","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.","volume":"10","author":"Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R3-12-20210202","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eimc.2015.03.001","article-title":"Meningococcal vaccines. Global epidemiological situation and strategies for prevention by vaccination.","volume":"33","author":"Rivero Calle","year":"2015","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R4-12-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erv.10.3","article-title":"The epidemiology of meningococcal disease and the impact of vaccines.","volume":"9","author":"Khatami","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"R5-12-20210202","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1586\/erv.11.103","article-title":"Neisseria meningitidis B vaccines.","volume":"10","author":"Panatto","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"R6-12-20210202","first-page":"100","article-title":"Centro Nacional de Epidemiologia. Instituto Carlos III. Comentario epidemiologico de las enfermedades de declaracion obligatoria y sistema de informacion microbiologica. Espana. Ano 2010.","volume":"19","author":"de Vigilancia Epidemiologica","year":"2011","journal-title":"Bol Epidemiol Sem"},{"key":"R7-12-20210202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/eri.13.42","article-title":"The burden and impact of severe and long-term sequelae of meningococcal disease.","volume":"11","author":"Vyse","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R8-12-20210202","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40265-013-0079-2","article-title":"Meningococcal vaccines: current issues and future strategies.","volume":"73","author":"Cohn","year":"2013","journal-title":"Drugs"},{"key":"R9-12-20210202","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1586\/14787210.2014.966079","article-title":"Prognostic markers of meningococcal disease in children: recent advances and future challenges.","volume":"12","author":"Montero-Martin","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R10-12-20210202","doi-asserted-by":"crossref","first-page":"e876","DOI":"10.1542\/peds.2014-2941","article-title":"13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants.","volume":"135","author":"Martinon-Torres","year":"2015","journal-title":"Pediatrics"},{"key":"R11-12-20210202","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease.","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"key":"R12-12-20210202","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol"},{"key":"R13-12-20210202","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3109\/02699052.2011.613090","article-title":"Health-related quality-of-life and behavioural outcome in survivors of childhood meningitis.","volume":"25","author":"Sumpter","year":"2011","journal-title":"Brain Inj"},{"key":"R14-12-20210202","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00431-010-1390-5","article-title":"Long-term outcomes of pneumococcal meningitis in childhood and adolescence.","volume":"170","author":"Christie","year":"2011","journal-title":"Eur J Pediatr"},{"key":"R15-12-20210202","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1542\/peds.2008-0581","article-title":"Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study.","volume":"123","author":"Borg","year":"2009","journal-title":"Pediatrics"},{"key":"R17-12-20210202","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1097\/00003246-200007000-00072","article-title":"Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments.","volume":"28","author":"Fiser","year":"2000","journal-title":"Crit Care Med"},{"key":"R18-12-20210202","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/00003246-200004000-00043","article-title":"Relationship of illness severity and length of stay to functional outcomes in the pediatric intensive care unit: a multi-institutional study.","volume":"28","author":"Fiser","year":"2000","journal-title":"Crit Care Med"},{"key":"R19-12-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1871526515999150320155614","article-title":"Complications of serogroup B meningococcal disease in survivors: a review.","volume":"14","author":"Dastouri","year":"2014","journal-title":"Infect Disord Drug Targets"},{"key":"R20-12-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/adc.2007.131862","article-title":"Long-term skin scarring and orthopaedic sequelae in survivors of meningococcal septic shock.","volume":"94","author":"Buysse","year":"2009","journal-title":"Arch Dis Child"},{"key":"R21-12-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.bpo.0000187991.71645.e7","article-title":"Orthopaedic sequelae of meningococcal septicemia.","volume":"26","author":"Bache","year":"2006","journal-title":"J Pediatr Orthop"},{"key":"R22-12-20210202","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/INF.0b013e3182706b89","article-title":"Members of Canadian Immunization Monitoring Program, Active (IMPACT). The disease burden of invasive meningococcal serogroup B disease in Canada.","volume":"32","author":"Bettinger","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R23-12-20210202","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/520303","article-title":"Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.","volume":"26","author":"Erickson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R24-12-20210202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00365549609027149","article-title":"Clinical manifestations and course of meningococcal disease in 562 patients.","volume":"28","author":"Schildkamp","year":"1996","journal-title":"Scand J Infect Dis"},{"key":"R25-12-20210202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erv.09.48","article-title":"Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.","volume":"8","author":"Trotter","year":"2009","journal-title":"Expert Rev Vaccines"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:09:53Z","timestamp":1620954593000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201604000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001048","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}